H1927: An Act relative to the substitution of interchangeable
biosimilars; H3667: An Act
relative to the substitution of interchangeable biosimilars
|
Neutral
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$402.55
|
Updates to Office of Patient Protection Regulation 958 CMR 3.000 - Health Insurance Consumer Protection
|
Neutral
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$402.55
|
H2018: An Act to define modest meals and refreshments in prescriber educational settings; S1050: An Act to reduce health care costs by promoting evidence-based prescriber education; S1051: An Act to prevent undue influence on prescriber behavior; S1052: An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$644.08
|
H2020: An Act to reduce healthcare costs by promoting non-biased prescriber education
|
Oppose
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$161.02
|
H2061: An Act prohibiting advertising by pharmaceutical companies
|
Oppose
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$402.55
|
H2082: An Act establishing a statewide discount program for pharmaceuticals
|
Oppose
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$161.02
|
H2084: An Act relative to keep people healthy by removing barriers to cost-effective care
|
Oppose
|
N/A
| Pharmaceutical Research and Manufacturers of America (PhRMA) |
$402.55
|
| | | Total amount |
$2,576.32
|